Changes in Eating Behavior and Food Preferences After Semaglutide or Tirzepatide Initiation: A Prospective Observational Pilot Study
Nutrients · 05.11.2026 · 18 (21) · 3675
DOI: 10.3390/nu18213675 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, online erschienen am 05.11.2026. Verfasst von Elisabetta Camajani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Open University, Via di Val Cannuta, 247, 00166 Rome, Italy. Hauptthemen laut MEDLINE: Tirzepatide, Feeding Behavior, Obesity, Glucagon-Like Peptides. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health.
Abstract (Originalsprache)
Background
This pilot study evaluated changes in eating behavior, appetite, and dietary habits during semaglutide or tirzepatide treatment in adults with obesity.
Methods
In this prospective observational study, 38 non-diabetic adults with obesity (mean age 56.1 ± 11.3 years; 73.7% female; BMI 32.7 ± 4.5 kg/m2) initiating semaglutide (n = 21) or tirzepatide (n = 17) were assessed at baseline and after 3 months. Clinical parameters and self-reported eating behaviors were evaluated using standardized measurements and a study-specific questionnaire.
Results
Mean body weight decreased by 7.2 ± 4.9 kg (p < 0.001), and systolic blood pressure decreased by 6.1 ± 6.3 mm Hg (p < 0.001). Cravings for sweet and savory foods, difficulty resisting hunger between meals, and daily meal frequency decreased, whereas perceived meal-induced satiety increased (all p ≤ 0.005). A substantial reduction in meal portion size was reported by 84.2% of participants. Reported food-group consumption changed, but improved overall dietary quality was not established.
Conclusions
Over 3 months, incretin-based treatment was accompanied by weight loss and changes in self-reported eating behavior. The observational design, absence of a control group, and unvalidated questionnaire limit interpretation. Larger controlled studies using validated measures are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Open University, Via di Val Cannuta, 247, 00166 Rome, Italy.
- Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Roma, Via di Val Cannuta, 247, 00166 Rome, Italy.
- Campus Bio-Medico University of Rome, 00128 Rome, Italy.
- Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London E1 4NS, UK.
ORCID-Profile: Elisabetta Camajani, Francesco Frigerio, Andrea Armani, Stefania Gorini, Tiziana Filardi, Massimiliano Caprio, Mauro Lombardo
Förderung
- Ministry of Health
Zitieren
APA
Camajani, E., Frigerio, F., Quattrini, C., Franzese, V., Armani, A., Gorini, S., Filardi, T., Feraco, A., Caprio, M., & Lombardo, M. (2026). Changes in Eating Behavior and Food Preferences After Semaglutide or Tirzepatide Initiation: A Prospective Observational Pilot Study. Nutrients, 18(21), 3675. https://doi.org/10.3390/nu18213675
Vancouver
Camajani E, Frigerio F, Quattrini C, Franzese V, Armani A, Gorini S, et al. Changes in Eating Behavior and Food Preferences After Semaglutide or Tirzepatide Initiation: A Prospective Observational Pilot Study. Nutrients. 2026;18(21):3675. doi:10.3390/nu18213675
BibTeX
@article{Camajani2026,
author = {Camajani, Elisabetta and Frigerio, Francesco and Quattrini, Chiara and Franzese, Valentina and Armani, Andrea and Gorini, Stefania and Filardi, Tiziana and Feraco, Alessandra and Caprio, Massimiliano and Lombardo, Mauro},
title = {Changes in Eating Behavior and Food Preferences After Semaglutide or Tirzepatide Initiation: A Prospective Observational Pilot Study},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {21},
pages = {3675},
doi = {10.3390/nu18213675}
}
EUVIMED